Status:

COMPLETED

Conditioned Placebo Effects and Treatment of Hypertension

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cardiovascular Diseases

Heart Diseases

Eligibility:

All Genders

Up to 100 years

Phase:

PHASE2

Brief Summary

To compare the unconditioned and conditioned effects of placebo capsules in the treatment of patients with borderline hypertension (BH).

Detailed Description

DESIGN NARRATIVE: This study will compare the unconditioned and conditioned effects of placebo capsules in the treatment of patients with borderline hypertension (BH). The use of placebos is routine ...

Eligibility Criteria

Inclusion

  • No eligibility criteria

Exclusion

    Key Trial Info

    Start Date :

    September 1 2002

    Trial Type :

    INTERVENTIONAL

    End Date :

    July 1 2007

    Estimated Enrollment :

    Patients enrolled

    Trial Details

    Trial ID

    NCT00269269

    Start Date

    September 1 2002

    End Date

    July 1 2007

    Last Update

    February 18 2016

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.